Prospective evaluation of pre-treatment ctDNA burden in localized osteosarcoma to identify patients with inferior outcomes: A report from the LEOPARD study.
Year: 2024
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: David Stephen Shulman, Kelly S. Klega, Nan Chen, Elliot Gohn, Donovan Henry, Edwin Choy, Thomas Cash, Kris Ann Pinekenstein Schultz, Leo Mascarenhas, Rochelle Bagatell, Brian Turpin, Bhuvana Setty, Bradley DeNardo, Douglas S. Hawkins, Michael W. Bishop, Avanthi T Shah, Luke Devon Maese, Wendy B London, Steven G. DuBois, Brian D. Crompton
Institutions: Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Massachusetts General Hospital, Children's Healthcare of Atlanta, Children's Minnesota, Cedars-Sinai Medical Center, Children's Hospital of Philadelphia, Cincinnati Children's Hospital Medical Center, Nationwide Children's Hospital, The Ohio State University, Lifespan, Seattle Children's Hospital, St. Jude Children's Research Hospital, The University of Texas Southwestern Medical Center, University of Utah, Huntsman Cancer Institute
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4399629283